Medical Research · GA
Odylia Therapeutics Inc
Odylia Therapeutics Inc reported paying Ashley Winslow, Ceo/cso, $225,220 in total compensation (FY 2024).
That places Ashley Winslow at approximately the 97th percentile among 152 similarly sized medical research nonprofits (median $75,730).
$482,047Total revenue (FY 2024)
$225,220Total executive compensation
97thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for Odylia Therapeutics Inc — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to GA cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Parkinson Association Of | NC | $482,140 | $80,297 |
| American Cochlear Implant Alliance | VA | $483,427 | $193,376 |
| St Louis Life Sciences Project | MO | $479,877 | $218,888 |
| American Board Of Medical Specialties | IL | $484,417 | $115,357 |
| Global Vitiligo Foundation | PA | $478,511 | $85,459 |
| Autism Tree Project Inc | CA | $477,889 | $77,291 |
| Central New York Lyme And | NY | $486,936 | $96,269 |
| Tom Slick Memorial Trust For Sw | TX | $487,198 | $66,959 |